Correlated regions of cerebral blood flow with clinical parameters in Parkinson's disease; Comparison using 'Anatomy' and 'Talairach Daemon' software

Annals of Nuclear Medicine

Volumn 26, Issue 2, 2012, Pages 164-174

  Yoon, Hyun Jin ^a   Cheon, Sang Myung ^a   Jeong, Young Jin ^a   Kang, Do Young ^a  

^a Dong A University   (South Korea)

Author keywords

Clinical parameters; Parkinson's disease (PD); Probabilistic cyto architectonic maps; SPECT; SPM8

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGE; AGED; ARTICLE; BRAIN BLOOD FLOW; CLINICAL FEATURE; COMPUTER PROGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RADIOPHARMACEUTICALS; SOFTWARE; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84858704796     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-011-0547-2     Document Type: Article

References (31)

1. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol. 2006;5(1):75-86. (Pubitemid 41790698)
2. Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R. Statistical parametric mapping of 99mTc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med. 2004;45(6):933-42. (Pubitemid 47611679)
3. Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med. 1999;40(10):1583-9. (Pubitemid 29471145)
4. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord. 2006;21(9):1343-9. (Pubitemid 44613283)
5. Kim JW, Jo HY, Park MJ, Cheon SM. Mild cognitive impairment in Parkinson's disease. J Mov Disord. 2008;1(1):19-25.
6. Kim JW, Cheon SM, Park MJ, Kim SY, Jo HY. Cognitive impairment in Parkinson's disease without dementia: subtypes and influences of age. J Clin Neurol. 2009;5:133-138.
7. Pillon B, Dubois B, Agid Y. Testing cognition may contribute to the diagnosis of movement disorders. Neurology. 1996;46(2):329-34.
8. Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci. 2001;22(1):45-6. (Pubitemid 33622083)
9. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, et al. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage. 2005;25(4):1325-35. (Pubitemid 40591672)
10. Eickhoff SB, Heim S, Zilles K, Amunts K. Testing anatomically specified hypotheses in functional imaging using cytoarchitectonic maps. Neuroimage. 2006;32(2):570-82. (Pubitemid 44149163)
11. Eickhoff SB, Paus T, Caspers S, Grosbras MH, Evans AC, Zilles K, et al. Assignment of functional activations to probabilistic cytoarchitectonic areas revisited. Neuroimage. 2007;36(3):511-21. (Pubitemid 46907638)
12. Benoit M, Clairet S, Koulibaly P, Darcourt J, Robert P. Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease. Int J Geriatr Psychiatry. 2004;19(9):864-9. (Pubitemid 39242892)
13. Anatomy 1.7. http://www.fz-juelich.de/inm/inm-1/spm-anatomy-toolbox. Accessed 12 July 2010.
14. Chang L. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25(1):638-43.
15. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp. 1994;2(4):189-210. (Pubitemid 124008664)
16. Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ. Spatial registration and normalization of images. Hum Brain Mapp. 1995;3(3):165-89. (Pubitemid 3036540)
17. Friston K, Holmes A, Poline J, Price C, Frith C. Detecting activations in PET and fMRI: levels of inference and power. Neuroimage. 1996;4(3):223-35.
18. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme; 1988.
19. SPM8. http://www.fil.ion.ucl.ac.uk/spm/software/spm8. Accessed1 July 2010.
20. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp. 2000;10(3):120-31. (Pubitemid 30456920)
21. Morbelli S, Rodriguez G, Mignone A, Altrinetti V, Brugnolo A, Piccardo A, et al. The need of appropriate brain SPECT templates for SPM comparisons. Q J Nucl Med Mol Imaging. 2008;52(1):89-98. (Pubitemid 351351048)
22. Lee JS, Lee DS, Oh SH, Kim CS, Kim JW, Hwang CH, et al. PET evidence of neuroplasticity in adult auditory cortex of postlingual deafness. J Nucl Med. 2003;44(9):1435-9.
23. Talairach Daemon 2.4.2. http://www.talairach.org/. Accessed 8 May 2010.
24. Schleicher A, Palomero-Gallagher N, Morosan P, Eickhoff S, Kowalski T, Vos K, et al. Quantitative architectural analysis: a new approach to cortical mapping. Anat Embryol. 2005;210(5):373-86. (Pubitemid 41752597)
25. Schleicher A, Morosan P, Amunts K, Zilles K. Quantitative architectural analysis: a new approach to cortical mapping. J Autism Dev Disord. 2009;39(11):1568-81.
26. Osaki Y, Morita Y, Fukumoto M, Akagi N, Yoshida S, Doi Y. Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia. Mov Disord. 2005;20(8):999-1005. (Pubitemid 41419517)
27. Hu M, Taylor-Robinson S, Chaudhuri K, Bell J, Labbe C, Cunningham V, et al. Cortical dysfunction in non-demented Parkinson's disease patients: a combined 31P-MRS and 18FDG-PET study. Brain. 2000;123(2):340-52. (Pubitemid 30055157)
28. Oishi N, Udaka F, Kameyama M, Sawamoto N, Hashikawa K, Fukuyama H. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology. 2005; 65(11):1708-15.
29. Mito Y, Yoshida K, Yabe I, Makino K, Hirotani M, Tashiro K, et al. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease. Clin Neurol Neurosurg. 2005;107(5):396-403. (Pubitemid 40980384)
30. Lee MC, Bae SK, Lee MH, Chung JK, Koh CS, Roh JK, et al. Quantitative analysis of regional cerebral blood flow using 99mTc-HMPAO SPECT in Parkinson's disease. Korean J Nucl Med. 1992;26:251-6.
31. Wolf U, Rapoport MJ, Schweizer TA. Evaluating the affective component of the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci. 2009;21(3):245-53.